We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Committee Calls for Randomized Trials in Accelerated Approvals
Advisory Committee Calls for Randomized Trials in Accelerated Approvals
February 11, 2011
Drugmakers conducting postmarket clinical trials should be required to conduct randomized trials, according to the FDA’s Oncologic Drugs Advisory Committee.